Table 1 Chemoprophylactic effect of azithromycin monotherapy against Plasmodium falciparum in semi-immune non-pregnant adults.
From: Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy
Country | Treatment regimen | Sample size | Duration of follow-up | Chemoprophylactic effect (95% CI) |
|---|---|---|---|---|
Kenya [40] | 250 mg daily | 59 | 10 weeks | 83% (68–91) |
Kenya [40] | 1,000 mg weekly | 58 | 10 weeks | 64% (47–77) |
Indonesia [36] | 750 mg loading dose and 250 mg daily | 148 | 20 weeks | 72% (50–84) |
Thailand [37] | 750 mg loading dose and 250 mg daily | 179 | 20 weeks | 71% (-14–94) |